PITTSBURGH, PA — (Marketwire) — 11/02/11 — HWI Global®, (OTCBB: HWIC), the Pittsburgh-based clean room design builder, has been awarded the contract to provide specialized design and build construction services for the new KCC B2-Stem Cell Cellular Therapy Laboratory Renovations at Mt. Sinai Medical Center. Set to begin in December, this project will run simultaneously with a second project HWI® recently awarded, a USP 797 sterile compounding clean room renovation. HWI® currently holds the annual preventative maintenance contract for the 6th Floor Pharmacy clean room.
Deric Haddad, CEO, HWI Global®, states, “Having the opportunity to expand our services at Mt. Sinai beyond USP 797 pharmacy clean rooms and into the realm of stem cell therapy is a forward step for the Company. We did provide turnkey design-build services on two projects for Stemnion, a regenerative medicine company based in Pittsburgh, but now we have entered into stem cell applications within our existing Hospital clientele. And, of course, we are always pleased to expand our relationship with Mt. Sinai.”
HWI® was specified for this project by Mitchell Architectural Group of Southbury, Connecticut. The Company is subcontracted by Hunter Roberts Construction Group-s New York City branch.
About HWI Global®
HWI Global, Inc.® is a leader in clean room design engineering and construction servicing clients in the Life Science, Health Science, Nanotechnology, Microelectronics, and Aerospace industries. Since its incorporation in 2004, HWI Global® has effectively constructed classified facilities for R&D, food & beverage, contract manufacturers, and OEM providers. From low volume sterile compounding to high volume manufacturing and packaging applications, HWI Global® provides value-engineered solutions for any custom clean room condition. HWI Global® and its network of subject matter experts — from leading architects, engineers, facilities planners, and specialized installers — effectively design and construct state-of-the-art clean environments in a “turnkey” fashion. For more information, please visit our website at
Forward-looking Statements
Except for the historical information and discussions contained herein, statements contained in this release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Our forward-looking statements are subject to risks and uncertainties. The risks and uncertainties that could cause actual results to differ materially, include, among others, limited access to capital, additional financing requirements, competition, the ability to attract and retain qualified employees, the ability to execute our strategy, the uncertainty of our future operating performance, the inability to manage growth, compliance with government regulations and legal liabilities, the effect of economic conditions in the business sectors in which we operate, and other uncertainties described in the Company-s filings with the Securities and Exchange Commission. Many of these factors are beyond our ability to predict or control. In addition, as a result of these and other factors, our past financial performance should not be relied on as an indication of future performance. The Company does not assume any obligation to update any forward-looking statements or other information contained in this news release.
Contact:
Investor Relations:
Mark Kabbash
646-408-2661
or
Media Relations:
Jerry Jennings
561-881-7318
You must be logged in to post a comment Login